Catherine Lanagan
The University of Queensland(AU)Mater Research(AU)
Publications by Year
Research Areas
Melanoma and MAPK Pathways, DNA Repair Mechanisms, Cutaneous Melanoma Detection and Management, Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencing(2011)195 cited
- → Durable complete clinical responses in a phase I/II trial using an autologous melanoma cell/dendritic cell vaccine(2003)186 cited
- → miR-514a regulates the tumour suppressor NF1 and modulates BRAFi sensitivity in melanoma(2015)95 cited
- → Dendritic cell immunotherapy for stage IV melanoma(2007)51 cited
- → Endogenous Replication Stress Marks Melanomas Sensitive to CHEK1 Inhibitors In Vivo(2018)28 cited
- → Combined use of subclinical hydroxyurea and CHK1 inhibitor effectively controls melanoma and lung cancer progression, with reduced normal tissue toxicity compared to gemcitabine(2019)23 cited
- → Immunological characteristics correlating with clinical response to immunotherapy in patients with advanced metastatic melanoma(2006)21 cited
- → Melanoma mutations modify melanocyte dynamics in co-culture with keratinocytes or fibroblasts(2019)6 cited
- → High Efficiency Ex Vivo Cloning of Antigen-Specific Human Effector T Cells(2014)5 cited